Johns Hopkins ABX Guide
Amphotericin B liposomal
INDICATIONS
FDA
FDA
- Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Empiric therapy for presumed fungal infection in patients with febrile neutropenia
- Visceral leishmaniasis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Zygomycetes and other invasive molds
- Coccidioidomycosis
- Histoplasmosis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 8, 2026
Citation
, Caitlin Soto, PharmD, BCIDP. "Amphotericin B Liposomal." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540022/6/Amphotericin_B_liposomal.
C. Amphotericin B liposomal. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540022/6/Amphotericin_B_liposomal. Accessed March 19, 2026.
, C. (2026). Amphotericin B liposomal. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540022/6/Amphotericin_B_liposomal
C. Amphotericin B Liposomal [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 March 19]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540022/6/Amphotericin_B_liposomal.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amphotericin B liposomal
ID - 540022
A1 - ,Caitlin Soto, PharmD, BCIDP,
Y1 - 2026/03/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540022/6/Amphotericin_B_liposomal
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
